Int J Gynecol Cancer 2020 Dec 18
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
ABSTRACT
A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide.
Related Questions
If the patient had high risk features (for example age 60+ and LVI) do you treat with vaginal brachytherapy or WPRT? If you treat with whole pelvis ra...
New comment by Radiation Oncologist at Mon Health ( April 9, 2023)
Thank you @Sushil.
New answer by Radiation Oncologist at Varian Medical Systems/Allegheny health network (February 20, 2022)
Currently, most treat with sequential chemotherapy plus EBRT. Although if it is POLE type, then the value of chemotherapy is debatable (PORTEC-3) and that’s why current ...
New answer by Radiation Oncologist at Vanderbilt-Ingram Cancer Center (April 27, 2022)
The NCCN guidelines prefer cuff brachytherapy for all stage IA non-invasive serous endometrial cancers which is my general practice. I advocate for vaginal cuff brachytherapy ...
How does your approach differ for patients under age 60, between 60-70, and over age 70?
New answer by Radiation Oncologist at Varian Medical Systems/Allegheny health network (February 20, 2023)
These attached guidelines recommend consideration of chemo if IA with myometrial invasion. From a radiation perspective, I do brachy alone with consideration of chemotherapy.&...